<DOC>
	<DOCNO>NCT00005002</DOCNO>
	<brief_summary>The purpose study see effective add HIV vaccine ( Remune ) anti-HIV drug combination Combivir ( zidovudine plus lamivudine ) nelfinavir .</brief_summary>
	<brief_title>Effectiveness Treating HIV-Positive Patients With HIV Vaccine ( Remune )</brief_title>
	<detailed_description>All patient begin HAART study entry ( Day 1 ) . Patients plasma HIV-1 RNA level less equal 2,000 copies/ml Week 8 randomize receive Remune Incomplete Freund 's Adjuvant ( IFA ) Week 9 . Patients achieve plasma HIV-1 RNA level less equal 2,000 copies/ml Week 8 randomize terminate study . These patient eligible receive funding 3-month supply nelfinavir ( Viracept ) Combivir . Randomized patient receive Remune IFA Week 9 approximately every 12 week thereafter study completion ( last patient reach Week 48 ) . Patients consider virologic failure ( 1 ) fail achieve virologic response Week 48 ( 2 ) achieve virologic response , virologic relapse . Regardless previous response status , patient whose plasma HIV-1 RNA level increase great 2,000 copies/ml receive protocol-specified HAART eligible receive salvage therapy continue receive Remune IFA study completion . Study visit occur screen , Day 1 , Weeks 4 , 8 , 9 , 12 , every 4 week thereafter last patient reach Week 48 . Patients complete study eligible participate rollover study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Are least 13 year old ( consent parent guardian require 18 ) . Have viral load least 10,000 copies/ml . Have CD4 count least 250 cells/mm3 . Have never take antiHIV drug .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2001</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>CD4 Lymphocyte Count</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>remune</keyword>
	<keyword>Combivir</keyword>
</DOC>